Mapp Biopharmaceutical Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 73

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $900K

Mapp Biopharmaceutical General Information

Description

Developer of novel pharmaceuticals designed for the prevention and treatment of infectious diseases. The company develops monoclonal antibody-based therapies and prophylactic candidates targeting emerging infectious diseases and biodefense-related health threats, enabling healthcare systems, government agencies, and public health organizations to access medical countermeasures for outbreak preparedness and disease management.

Contact Information

Website
www.mappbio.com
Formerly Known As
LeafBio
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 4921 Directors Place
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 4921 Directors Place
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mapp Biopharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 14-Oct-2022 $900K Completed Clinical Trials - General
To view Mapp Biopharmaceutical’s complete valuation and funding history, request access »

Mapp Biopharmaceutical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel pharmaceuticals designed for the prevention and treatment of infectious diseases. The company develop
Drug Discovery
San Diego, CA
73 As of 2026

Cranbury, NJ
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mapp Biopharmaceutical Competitors (25)

One of Mapp Biopharmaceutical’s 25 competitors is PeproTech, a Corporate Backed or Acquired company based in Cranbury, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PeproTech Corporate Backed or Acquired Cranbury, NJ
Novavax Corporation Gaithersburg, MD
Celldex Formerly VC-backed Hampton, NJ
BPS Bioscience Corporation San Diego, CA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 5 of 25 competitors. Get the full list »

Mapp Biopharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mapp Biopharmaceutical Investments (1)

Mapp Biopharmaceutical’s most recent deal was a Joint Venture with Monoclonal Antibody Drugs for Hemorrhagic Fever Viruses (Defyrus / Mapp Biopharmaceutical). The deal was made on 29-Jul-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Monoclonal Antibody Drugs for Hemorrhagic Fever Viruses (Defyrus / Mapp Biopharmaceutical) 29-Jul-2013 Joint Venture Buildings and Property
To view Mapp Biopharmaceutical’s complete investments history, request access »

Mapp Biopharmaceutical FAQs

  • When was Mapp Biopharmaceutical founded?

    Mapp Biopharmaceutical was founded in 2003.

  • Where is Mapp Biopharmaceutical headquartered?

    Mapp Biopharmaceutical is headquartered in San Diego, CA.

  • What is the size of Mapp Biopharmaceutical?

    Mapp Biopharmaceutical has 73 total employees.

  • What industry is Mapp Biopharmaceutical in?

    Mapp Biopharmaceutical’s primary industry is Drug Discovery.

  • Is Mapp Biopharmaceutical a private or public company?

    Mapp Biopharmaceutical is a Private company.

  • What is Mapp Biopharmaceutical’s current revenue?

    The current revenue for Mapp Biopharmaceutical is .

  • How much funding has Mapp Biopharmaceutical raised over time?

    Mapp Biopharmaceutical has raised $900K.

  • Who are Mapp Biopharmaceutical’s competitors?

    PeproTech, Novavax, Celldex, BPS Bioscience, and Ability Pharma are some of the 25 competitors of Mapp Biopharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process